Dr. George K. Philips, MBBS, MD, MPH

Dr. Philips practices at Medstar Georgetown Medical Center in Washington, District of Columbia.

Dr. Philips' NPI, 1558455378, was assigned on October 3, 2006. Dr. Philips holds Vermont license 0420009863.

Dr. Philips' primary practice is Medstar Georgetown Medical Center, at 3800 Reservoir NW Rd, Washington, DC 20007 in District Of Columbia County. The practice phone is (202) 444-1400.

Dr. Philips' primary practice is Medstar Georgetown Medical Center in Washington, District of Columbia. Dr. Philips is also affiliated with MedStar Washington Hospital Center. The medical group on file is MedStar Medical Group. Dmand AI also links Dr. Philips to 1 more hospital and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Philips practices, 2 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Philips' primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Philips is licensed in Vermont.

CMS data shows 866 Medicare services from Dr. Philips across 7 procedure codes in 2024, for 266 Medicare patients. Medicare paid $91,286 for them.

CMS counts 266 Medicare patients who saw Dr. Philips in 2024. The largest group is 75 to 84, with 121 patients. 75% of them have cancer, and 75% have high blood pressure. 21% are also on Medicaid. Their average risk score is 2.21, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Philips' median patient age at 72, with 8% women.

In 2024, Dr. Philips wrote 1,153 Medicare Part D claims for 145 patients. 39% of them were for generic drugs. CMS names the drug for 1,037 of them, across 13 drugs with 11 or more claims each, at $6,859,932 in total drug cost. In 2023, CMS named 580 claims across 13 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Philips for performance year 2024, reported as part of a group. Dr. Philips accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 17 papers to Dr. Philips, published from 2010 to 2021. 2017 was the busiest year, with 3. The most frequent topics are Antibodies, Monoclonal, Humanized, Antineoplastic Agents and Carcinoma, Renal Cell. Dr. Philips' most frequent co-authors are Sumati Virendra Gupta, MD, David S. Aaronson, MD and Robert S. Alter, MD.

Dmand AI links Dr. Philips to 3 clinical trials, 2 of them phase 2 studies. 2 are still active or recruiting. Conditions studied include Ureteral Neoplasms, Prostatic Neoplasms and Prostatic Diseases. National Cancer Institute (NCI) sponsors the most, 2.

CMS Open Payments shows 20 general payments to Dr. Philips from 9 drug and device companies from 2016 to 2024. Consulting fees make up the largest share, 52% of the total. Janssen Pharmaceuticals, Inc paid the most, $2,140.